Novus Diagnostics has secured €4.6 million in equity financing

Novus Diagnostics has secured €4.6 million in equity financing to accelerate the development of its rapid point-of-care sepsis diagnostic technology.
The investment includes a previously announced €2.5 million investment in the firm from Nasdaq-listed Trinity Biotech, as well as BVP and IRRUS INVESTMENTS. Novus is led by Keith O'Neill and Elaine Spain

7 February 2025
5 min read

https://www.businesspost.ie/tech/dcu-spin-out-novus-raises-e4-6m-for-sepsis-diagnostic-tool/

 

Novus Diagnostic